Jolijn C. Bethlem, Jenny A. H. M. Janssens, & Milan Tjioe. (2023). Real‐world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch). Wiley.
Chicago Style (17th ed.) CitationJolijn C. Bethlem, Jenny A. H. M. Janssens, and Milan Tjioe. Real‐world Drug Survival of Brodalumab, in Patients with Psoriasis Switched from Ixekizumab: Results of a Single Centre Retrospective Study (BroSwitch). Wiley, 2023.
MLA (9th ed.) CitationJolijn C. Bethlem, et al. Real‐world Drug Survival of Brodalumab, in Patients with Psoriasis Switched from Ixekizumab: Results of a Single Centre Retrospective Study (BroSwitch). Wiley, 2023.
Warning: These citations may not always be 100% accurate.